Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

E‐cadherin and aquaporin‐3 are downregulated in wound edges of human chronic wounds

E‐cadherin and aquaporin‐3 are downregulated in wound edges of human chronic wounds The skin forms a protective barrier against the external environment and thus, upon injury, the skin must rapidly undergo repair to restore barrier function (1). In the vast majority of cases, wound healing is uncomplicated with efficient healing within a few weeks. However, some wounds fail to proceed through the normal wound healing phases leading to chronic wounds, which is estimated to affect 1–2% of the human population worldwide (2, 3). This is especially prevalent in diabetic patients who are at increased risk of developing foot ulcers, which ultimately can lead to amputation. Chronic wounds are a major socioeconomic burden expected to increase with the rising number of diabetic and older patients, increase in obesity and the development of antibiotic resistance (3, 4).Skin wound healing is a complex process that can be divided into three continuous and overlapping phases: inflammation, proliferation and tissue remodeling (5). An important step during the proliferation phase is re‐epithelialization, which is responsible for restoring an intact epidermis during wound healing. Re‐epithelialization requires coordinated migration and proliferation of keratinocytes located at the wound edge or dermal appendages, including hair follicles and sweat glands. To successfully cover the wound, keratinocytes at the wound edge migrate collectively and coordinately into the wound followed by proliferation of keratinocytes behind the actively migrating cells (6–8).The epidermis is a stratified squamous epithelium with epidermal cells tightly connected by different cellular junctions: tight junctions, gap junctions, desmosomes and adherens junctions (9). These junctions are essential for skin barrier formation. E‐cadherin is the main transcellular adhesion protein in adherens junctions, and is expressed from stratum basale to stratum granulosum in human epidermal cells, where it is localized to the plasma membrane (10).Another important protein in the skin is aquaporin‐3 (AQP3), which is a channel protein facilitating transport of both water and glycerol across plasma membranes. AQP3 is expressed in human epidermal cells from stratum basale to stratum granulosum, where it is similarly localized to the plasma membrane (11–15). AQP3‐null mice suffered from dry skin; hence, AQP3 is thought to be important for glycerol uptake into keratinocytes and thus, skin hydration (16).Besides their canonical functions, both E‐cadherin and AQP3 are involved in multiple cellular processes including cell migration and proliferation and for AQP3, also cell–cell adhesion (17). In vitro studies of migrating epithelial cell sheets have shown that adherens junctions are essential for cells to migrate collectively (18), and that E‐cadherin is tightly regulated in collective cell migration during embryonal development, tumor metastasis, and wound healing (19, 20). In an acute wound model using human xenografts, a downregulation of E‐cadherin is observed in the wound front (21). AQPs are pivotal players in collective cell migration and it is thought that the facilitated water permeability aids in cell shape changes required for cell migration in restricted 3D environments (22). Moreover, AQPs at the leading edge of migrating cell sheets facilitate local cell swelling thought to provide space for actin polymerization and thereby increasing cell migration (22). AQP3‐deficient human keratinocytes display decreased collective cell migration and cell proliferation in vitro and delayed wound healing is observed in AQP3‐null mice (23). Also, in wounds on diabetic rats, both delayed wound healing and impaired AQP3 expression are observed (24).To our knowledge, no previous studies have investigated the expression of E‐cadherin and AQP3 in human chronic wounds. Since both E‐cadherin and AQP3 are important for skin function and collective cell migration, we hypothesized that the expression may be dysregulated. Thus, we examined the expression of E‐cadherin and AQP3 in the epidermis in biopsies taken at the wound edge of human chronic wounds. The staining was performed on serial sections to qualitatively evaluate staining patterns of E‐cadherin and AQP3 in the same regions. Immunohistochemical analysis revealed a decreased expression of both E‐cadherin and AQP3 in the edges of human chronic wounds compared to the expression in the epidermis near the wound edge.MATERIALS AND METHODSPatient tissue and ethics statementClinical samples were obtained through a prospective cohort study of patients suffering from chronic wounds planned for surgical debridement followed by split‐thickness skin grafting (STSG). The collection of samples from patients with chronic wounds was approved by the Danish Board of National Health ethics, protocol no.: H‐20032214.The samples (n = 9) were obtained as punch biopsies (4–6 mm) positioned at the wound edge so that the biopsy includes wound tissue with a brim of surrounding intact skin. The biopsies were obtained before surgical debridement and STSG. Biopsies were fixed in formalin and embedded in paraffin following standard operating procedures at the Department of Biomedical Sciences, University of Copenhagen, Denmark. All biopsies were cut with the maintained organization from the surrounding brim of skin toward the wound center and used for investigation of E‐cadherin and AQP3.Formalin fixed, paraffin‐embedded human control skin (n = 2) was obtained from the Department of Pathology, Aarhus University Hospital, Denmark. The Danish Act on Processing of Personal Data and Health was complied with, and since the material encompassed fully anonymized tissue, informed consent from patients was not required.ImmunohistochemistryParaffin‐embedded skin sections were deparaffinized overnight in xylene, rehydrated and endogenous peroxidase activity was blocked in 0.3% hydrogen peroxide in methanol. This was followed by heat‐mediated antigen retrieval in TEG buffer (10 mM Tris pH 9, 0.5 mM EGTA) and blocking of aldehyde groups in 50 mM NH4Cl in PBS for 30 min. The sections were washed in 1% bovine serum albumin (BSA), 0.2% gelatin and 0.05% saponin in PBS and labeled with mouse anti‐E‐cadherin (1:100, sc‐8426, Santa Cruz Biotechnology, Dallas, TX, USA) and rabbit anti‐AQP3 (1:400, AQP‐003, Alomone Labs, Jerusalem, Israel) antibodies diluted in 0.1% BSA and 0.3% Triton X‐100 in PBS in a humidity chamber at 4 °C overnight. The following day, the sections were allowed to adjust to room temperature, washed in 0.1% BSA, 0.2% gelatin and 0.05% saponin in PBS and incubated for 60 min in secondary horseradish peroxidase‐conjugated goat anti‐mouse (1:500, P0447, Agilent Technologies, Santa Clara, CA, USA) or goat anti‐rabbit antibodies (1:500, P0448, Agilent Technologies) and developed with 3,3′‐diaminobenzidine (DAB; K3468, Agilent Technologies). Finally, the sections were counterstained in Mayer's hematoxylin before dehydration and mounting. Staining of serial sections was performed to enable qualitative evaluation of staining patterns. No DAB reactivity was observed on negative control sections without incubation with primary antibodies. For histological evaluation, skin sections were stained with Mayer's hematoxylin and eosin.MicroscopyControl skin sections were imaged on a Leica DMLB bright‐field microscope equipped with a 20×/0.40 air objective and an Invenio 6EIII camera, which was controlled by Deltapix software. Wound edge skin sections were imaged on a Zeiss LSM 710 microscope equipped with a 10×/0.30 air objective and an Axiocam MRc camera, which was controlled by Zen Blue software. Image preparation was performed in ImageJ (25).RESULTS AND DISCUSSIONPatient dataAll samples from chronic wounds were obtained from lower extremity ulcers all located below knee level. Of the six patients included four were male (66.7%) and two were female (33.3%). The mean (SD) age was 75.7 (6.7) years with a range of 68–89 years. Diabetes was present in two (33.3%) of six patients. No patients were active smokers, four were former smokers and two had never smoked. All patients reported alcohol consumption within limits of the national recommendations by the Danish health government (<7 units/week). The mean (SD) wound age was 24.8 (SD 13.8) months. Four wounds were primarily attributed to chronic venous insufficiency (66.7%), one to arterial disease (16.7%), and one wound had a venous and an arterial component (16.7%).Histological evaluation of human chronic woundsSections of skin biopsies from the edge of human chronic wounds (n = 9) were stained with hematoxylin and eosin and histologically evaluated. A clear transition from intact epidermis to the wound edge, defined in this study by loss of epidermal cells, was observed in six out of nine chronic wound samples (Fig. 1A). The remaining three samples showed no loss of epidermis, indicating that the wound edge was not present in these samples, and therefore, they were excluded from the study (data not shown). Furthest from the wound edge, in the surrounding skin, the epidermis was intact and well organized with clear basal cell organization, which was in contrast to the decreased organization and thinner epidermis closer toward the wound edge. At the wound edge, the epidermis was disorganized prior to complete loss in the actual wound (Fig. 1A).1Fig.Histopathological evaluation of epidermis near and at the edge of human chronic wounds. (A) Representative images of a skin section from a human chronic wound stained with hematoxylin and eosin. The epidermis is intact and well‐organized 3 mm from the wound edge (left) and less organized 1 mm from the wound edge (middle). At the wound edge, the epidermis is disorganized and then disrupted (right). The black line marks the outline of the epidermis. (B) Representative images of sections from three chronic human wounds (1–3) stained with hematoxylin and eosin. In the intact epidermis near the chronic wound, different histological changes were observed among the patients, including hyperplastic epidermis (1 + 2), parakeratotic (1) and orthokeratotic (2) hyperkeratosis, hypergranulosis (2), spongiosis (2 + 3), elongated, thickened and irregular rete ridges (3), and dermal inflammation (3). Scale bar: 50 μm.In the intact epidermis near the wound edge, different histopathological characteristics were observed (Fig. 1B). The epidermis near the wound edge was intact and well organized, but showed epidermal hyperplasia (5 of 6) characterized by increased thickness of the epidermis due to an increased number of epidermal cells. In most of the samples, elongated, thickened, and/or irregular rete ridges were present (5 of 6). Hyperkeratosis, characterized by increased thickness of the stratum corneum, was observed in all samples with the presence of both non‐nucleated (orthokeratosis, 2 of 6) and nucleated (parakeratosis, 5 of 6) keratinocytes, indicating incomplete keratinocyte differentiation. Lastly, we observed different levels of epidermal intercellular edema (spongiosis, 5 of 6), characterized by widened intercellular spaces between epidermal cells with elongation of the intercellular junctions, and dermal inflammation (6 of 6; Fig. 1B).Our histopathological observations are consistent with previous studies of chronic wounds, reporting loss of the intact epidermis at the wound edge (26) and hyperplasia, hyperkeratosis and spongiosis in the intact epidermis near the wound edge (26–28).The expression of E‐cadherin and AQP3 is decreased in the epidermis of human chronic wound edgesTo investigate the expression of E‐cadherin and AQP3 in the wound edge of human chronic wounds, serial sections of control skin biopsies and chronic wound edge biopsies were immunohistochemically labeled with antibodies directed against E‐cadherin and AQP3. In control skin, E‐cadherin and AQP3 were localized to the plasma membrane of epidermal cells from stratum basale to stratum granulosum, as previously reported (10–12) (Fig. 2A). Lower expression of E‐cadherin and AQP3 was observed in stratum granulosum, whereas no immunolabeling was detected in stratum corneum and in the dermis (Fig. 2A), similarly to previous reports (10–12).2Fig.In chronic human wounds, the expression of E‐cadherin and AQP3 is downregulated in keratinocytes at the wound edge. (A) Immunohistochemical and hematoxylin and eosin staining of control human skin sections. Immunohistochemical evaluation of E‐cadherin and AQP3 in serial sections of control human skin demonstrates plasma membrane localization of both E‐cadherin and AQP3 in stratum basale (SB) and stratum spinosum (SS) (arrows). Lower expression of E‐cadherin and AQP3 was observed in stratum granulosum (SG) (arrowheads), whereas no immunolabeling was detected in stratum corneum (SC) and in the dermis. (B,C) Immunohistochemical staining of E‐cadherin and AQP3 in serial sections of human chronic wounds. (B) In intact epidermis, E‐cadherin and AQP3 are localized to the plasma membrane in stratum granulosum, stratum spinosum, and stratum basale near the wound edge (arrows), but with low expression in stratum basale in three of six samples. At the wound edge, E‐cadherin and AQP3 expression is markedly decreased (arrowheads). (C) Three different chronic wound edges demonstrating decrease of E‐cadherin and AQP3 expression. Scale bar: 30 μm.In the intact epidermis near the wound edge of all the human chronic wounds, E‐cadherin and AQP3 were observed in the plasma membrane of epidermal cells from stratum basale to stratum granulosum (6 of 6), but in some samples, low expression was observed in stratum basale (3 of 6). Closer to the wound edge, the epidermis was thinner and less organized, but plasma membrane localization of E‐cadherin and AQP3 could still be observed. At the wound edge, the expression of both E‐cadherin and AQP3 was markedly decreased in all samples (6 of 6; Fig. 2B). The wound edges were histologically very different, but common to all of the wounds was the decrease of E‐cadherin and AQP3 expression at the wound edge (Fig. 2C). Interestingly, regulation of E‐cadherin and AQP3 expression may be interdependent in skin since E‐cadherin is decreased in human keratinocytes after siRNA‐mediated knockdown of AQP3 (29).Like adherens junctions, tight junctions are also essential in collective cell migration in skin wound healing (30). Loss of tight junction proteins claudin‐1 and occludin has been observed in wound edges of human chronic wounds, whereas they were present in human acute wounds (31). We speculate if downregulation of tight junction proteins combined with adherens junctions at the wound edge of human chronic wounds might contribute to the pathophysiology of the chronic wounds by impairing skin repair due to decreased migratory capacity of the epidermal cells as well as reduced barrier function. However, E‐cadherin expression has been found to be almost absent in the wound front in an acute wound model using human skin xenograft (21). These observations are made in the wound front with intact epidermis, without any observations from the specific wound edge (transition from intact epidermis to loss of epidermal cells). In this study, we observe a downregulation of E‐cadherin in the wound edge of human chronic wounds. Further studies are needed to confirm if E‐cadherin is also downregulated at the wound edge of acute wounds.Since AQP3‐deficient human keratinocytes show decreased collective cell migration and cell proliferation in vitro and delayed wound healing is observed in AQP3‐null mice, reduced AQP3 expression may decrease migration of cells into the wound thereby contributing to the impaired wound healing in the chronic wounds. Besides defective cell migration, dysregulation of AQP3 expression has been shown to be involved in many different skin conditions. AQP3 expression is increased in the human epidermis of burn wounds and atopic eczema (32, 33) and mislocalized in human epidermis of psoriatic lesions (11).CONCLUSIONIn conclusion, we show a downregulation of E‐cadherin and AQP3 in the wound edge of human chronic wounds. Since there are no reports about AQP3 in the wound edge of human acute wounds, and E‐cadherin is downregulated in the wound front, not wound edge, of human acute wounds, further studies are needed to determine if the downregulation of E‐cadherin and AQP3 in chronic wounds is involved in the wounds failure to heal. If so, it should be determined if E‐cadherin and AQP3 are potential intervention targets for wound healing in chronic wounds and other skin diseases associated with dysregulation of adherens junctions and AQP3. The authors would like to express their gratitude to the nursing and medical staff at the Copenhagen Wound Healing Center, Bispebjerg Hospital and the patients who offered their participation and made it possible to collect samples from chronic wounds. We are also grateful to consultant pathologist, associate clinical professor, Henrik Hager, Department of Pathology, Aarhus University Hospital, for patient skin samples, and to Vibeke Secher Dam for technical assistance.FUNDINGCollection of samples from patients with chronic wounds was performed with financial support from Novo Nordisk Challenge Program (NNF19OC0056411) that also supported MD. A.K.S. Iversen. Novo Nordisk foundation (Tandem Program 2019 #0054390) generously provided financial support for Asst. Prof. L. Bay and Professor T. Bjarnsholt. This project was supported by a grant from the Graduate School of Health (ClinFO), Aarhus University, Denmark to C. Ernstsen.CONFLICT OF INTERESTThe authors declare that they have no conflicts of interest.REFERENCESBaroni A, Buommino E, De Gregorio V, Ruocco E, Ruocco V, Wolf R. Structure and function of the epidermis related to barrier properties. Clin Dermatol. 2012;30:257–62.Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 2009;17:763–71.Sen CK. Human wounds and its burden: an updated compendium of estimates. Adv Wound Care (New Rochelle). 2019;8:39–48.Falanga V, Isseroff RR, Soulika AM, Romanelli M, Margolis D, Kapp S, et al. Chronic wounds. Nat Rev Dis Primers. 2022;8:50.Martin P. Wound healing–aiming for perfect skin regeneration. Science. 1997;276:75–81.Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83:835–70.Friedl P, Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol. 2009;10:445–57.Usui ML, Mansbridge JN, Carter WG, Fujita M, Olerud JE. Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds. J Histochem Cytochem. 2008;56:687–96.Perez‐Moreno M, Jamora C, Fuchs E. Sticky business: orchestrating cellular signals at adherens junctions. Cell. 2003;112:535–48.Ohtani T, Memezawa A, Okuyama R, Sayo T, Sugiyama Y, Inoue S, et al. Increased Hyaluronan production and decreased E‐cadherin expression by cytokine‐stimulated keratinocytes lead to spongiosis formation. J Invest Dermatol. 2009;129:1412–20.Voss KE, Bollag RJ, Fussell N, By C, Sheehan DJ, Bollag WB. Abnormal aquaporin‐3 protein expression in hyperproliferative skin disorders. Arch Dermatol Res. 2011;303:591–600.Sougrat R, Morand M, Gondran C, Barre P, Gobin R, Bonte F, et al. Functional expression of AQP3 in human skin epidermis and reconstructed epidermis. J Invest Dermatol. 2002;118:678–85.Frigeri A, Gropper MA, Umenishi F, Kawashima M, Brown D, Verkman AS. Localization of MIWC and GLIP water channel homologs in neuromuscular, epithelial and glandular tissues. J Cell Sci. 1995;108:2993–3002.Agren J, Zelenin S, Svensson LB, Nejsum LN, Nielsen S, Aperia A, et al. Antenatal corticosteroids and postnatal fluid restriction produce differential effects on AQP3 expression, water handling, and barrier function in perinatal rat epidermis. Dermatol Res Pract. 2010;2010:789729.Agren J, Zelenin S, Hakansson M, Eklof AC, Aperia A, Nejsum LN, et al. Transepidermal water loss in developing rats: role of aquaporins in the immature skin. Pediatr Res. 2003;53:558–65.Hara‐Chikuma M, Verkman AS. Aquaporin‐3 functions as a glycerol transporter in mammalian skin. Biol Cell. 2005;97:479–86.Login FH, Jensen HH, Pedersen GA, Koffman JS, Kwon TH, Parsons M, et al. Aquaporins differentially regulate cell‐cell adhesion in MDCK cells. FASEB J. 2019;33:6980–94.Li L, Hartley R, Reiss B, Sun Y, Pu J, Wu D, et al. E‐cadherin plays an essential role in collective directional migration of large epithelial sheets. Cell Mol Life Sci. 2012;69:2779–89.Hunter MV, Lee DM, Harris TJ, Fernandez‐Gonzalez R. Polarized E‐cadherin endocytosis directs actomyosin remodeling during embryonic wound repair. J Cell Biol. 2015;210:801–16.Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig‐CAMs in cancer. Nat Rev Cancer. 2004;4:118–32.Kashgari G, Venkatesh S, Refuerzo S, Pham B, Bayat A, Klein RH, et al. GRHL3 activates FSCN1 to relax cell‐cell adhesions between migrating keratinocytes during wound reepithelialization. JCI. Insight. 2021;6:e142577.Papadopoulos MC, Saadoun S, Verkman AS. Aquaporins and cell migration. Pflugers Arch. 2008;456:693–700.Hara‐Chikuma M, Verkman AS. Aquaporin‐3 facilitates epidermal cell migration and proliferation during wound healing. J Mol Med (Berl). 2008;86:221–31.Sugimoto T, Huang L, Minematsu T, Yamamoto Y, Asada M, Nakagami G, et al. Impaired aquaporin 3 expression in reepithelialization of cutaneous wound healing in the diabetic rat. Biol Res Nurs. 2013;15:347–55.Schindelin J, Arganda‐Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open‐source platform for biological‐image analysis. Nat Methods. 2012;9:676–82.Misciali C, Dika E, Baraldi C, Fanti PA, Mirelli M, Stella A, et al. Vascular leg ulcers: histopathologic study of 293 patients. Am J Dermatopathol. 2014;36:977–83.Brem H, Stojadinovic O, Diegelmann RF, Entero H, Lee B, Pastar I, et al. Molecular markers in patients with chronic wounds to guide surgical debridement. Mol Med. 2007;13:30–9.Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, Stallcup M, et al. Molecular pathogenesis of chronic wounds: the role of beta‐catenin and c‐myc in the inhibition of epithelialization and wound healing. Am J Pathol. 2005;167:59–69.Kim NH, Lee AY. Reduced aquaporin3 expression and survival of keratinocytes in the depigmented epidermis of vitiligo. J Invest Dermatol. 2010;130:2231–9.Du D, Xu F, Yu L, Zhang C, Lu X, Yuan H, et al. The tight junction protein, occludin, regulates the directional migration of epithelial cells. Dev Cell. 2010;18:52–63.Volksdorf T, Heilmann J, Eming SA, Schawjinski K, Zorn‐Kruppa M, Ueck C, et al. Tight junction proteins Claudin‐1 and Occludin are important for cutaneous wound healing. Am J Pathol. 2017;187:1301–12.Sebastian R, Chau E, Fillmore P, Matthews J, Price LA, Sidhaye V, et al. Epidermal aquaporin‐3 is increased in the cutaneous burn wound. Burns. 2015;41:843–7.Olsson M, Broberg A, Jernae M, Carlsson L, Rudemo M, Suurkula M, et al. Increased expression of aquaporin 3 in atopic eczema. Allergy. 2006;61:1132–7. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Apmis Wiley

E‐cadherin and aquaporin‐3 are downregulated in wound edges of human chronic wounds

Loading next page...
 
/lp/wiley/e-cadherin-and-aquaporin-3-are-downregulated-in-wound-edges-of-human-mBtmM628I1

References (34)

Publisher
Wiley
Copyright
Copyright © 2023 APMIS Published by John Wiley & Sons Ltd.
ISSN
0903-4641
eISSN
1600-0463
DOI
10.1111/apm.13332
Publisher site
See Article on Publisher Site

Abstract

The skin forms a protective barrier against the external environment and thus, upon injury, the skin must rapidly undergo repair to restore barrier function (1). In the vast majority of cases, wound healing is uncomplicated with efficient healing within a few weeks. However, some wounds fail to proceed through the normal wound healing phases leading to chronic wounds, which is estimated to affect 1–2% of the human population worldwide (2, 3). This is especially prevalent in diabetic patients who are at increased risk of developing foot ulcers, which ultimately can lead to amputation. Chronic wounds are a major socioeconomic burden expected to increase with the rising number of diabetic and older patients, increase in obesity and the development of antibiotic resistance (3, 4).Skin wound healing is a complex process that can be divided into three continuous and overlapping phases: inflammation, proliferation and tissue remodeling (5). An important step during the proliferation phase is re‐epithelialization, which is responsible for restoring an intact epidermis during wound healing. Re‐epithelialization requires coordinated migration and proliferation of keratinocytes located at the wound edge or dermal appendages, including hair follicles and sweat glands. To successfully cover the wound, keratinocytes at the wound edge migrate collectively and coordinately into the wound followed by proliferation of keratinocytes behind the actively migrating cells (6–8).The epidermis is a stratified squamous epithelium with epidermal cells tightly connected by different cellular junctions: tight junctions, gap junctions, desmosomes and adherens junctions (9). These junctions are essential for skin barrier formation. E‐cadherin is the main transcellular adhesion protein in adherens junctions, and is expressed from stratum basale to stratum granulosum in human epidermal cells, where it is localized to the plasma membrane (10).Another important protein in the skin is aquaporin‐3 (AQP3), which is a channel protein facilitating transport of both water and glycerol across plasma membranes. AQP3 is expressed in human epidermal cells from stratum basale to stratum granulosum, where it is similarly localized to the plasma membrane (11–15). AQP3‐null mice suffered from dry skin; hence, AQP3 is thought to be important for glycerol uptake into keratinocytes and thus, skin hydration (16).Besides their canonical functions, both E‐cadherin and AQP3 are involved in multiple cellular processes including cell migration and proliferation and for AQP3, also cell–cell adhesion (17). In vitro studies of migrating epithelial cell sheets have shown that adherens junctions are essential for cells to migrate collectively (18), and that E‐cadherin is tightly regulated in collective cell migration during embryonal development, tumor metastasis, and wound healing (19, 20). In an acute wound model using human xenografts, a downregulation of E‐cadherin is observed in the wound front (21). AQPs are pivotal players in collective cell migration and it is thought that the facilitated water permeability aids in cell shape changes required for cell migration in restricted 3D environments (22). Moreover, AQPs at the leading edge of migrating cell sheets facilitate local cell swelling thought to provide space for actin polymerization and thereby increasing cell migration (22). AQP3‐deficient human keratinocytes display decreased collective cell migration and cell proliferation in vitro and delayed wound healing is observed in AQP3‐null mice (23). Also, in wounds on diabetic rats, both delayed wound healing and impaired AQP3 expression are observed (24).To our knowledge, no previous studies have investigated the expression of E‐cadherin and AQP3 in human chronic wounds. Since both E‐cadherin and AQP3 are important for skin function and collective cell migration, we hypothesized that the expression may be dysregulated. Thus, we examined the expression of E‐cadherin and AQP3 in the epidermis in biopsies taken at the wound edge of human chronic wounds. The staining was performed on serial sections to qualitatively evaluate staining patterns of E‐cadherin and AQP3 in the same regions. Immunohistochemical analysis revealed a decreased expression of both E‐cadherin and AQP3 in the edges of human chronic wounds compared to the expression in the epidermis near the wound edge.MATERIALS AND METHODSPatient tissue and ethics statementClinical samples were obtained through a prospective cohort study of patients suffering from chronic wounds planned for surgical debridement followed by split‐thickness skin grafting (STSG). The collection of samples from patients with chronic wounds was approved by the Danish Board of National Health ethics, protocol no.: H‐20032214.The samples (n = 9) were obtained as punch biopsies (4–6 mm) positioned at the wound edge so that the biopsy includes wound tissue with a brim of surrounding intact skin. The biopsies were obtained before surgical debridement and STSG. Biopsies were fixed in formalin and embedded in paraffin following standard operating procedures at the Department of Biomedical Sciences, University of Copenhagen, Denmark. All biopsies were cut with the maintained organization from the surrounding brim of skin toward the wound center and used for investigation of E‐cadherin and AQP3.Formalin fixed, paraffin‐embedded human control skin (n = 2) was obtained from the Department of Pathology, Aarhus University Hospital, Denmark. The Danish Act on Processing of Personal Data and Health was complied with, and since the material encompassed fully anonymized tissue, informed consent from patients was not required.ImmunohistochemistryParaffin‐embedded skin sections were deparaffinized overnight in xylene, rehydrated and endogenous peroxidase activity was blocked in 0.3% hydrogen peroxide in methanol. This was followed by heat‐mediated antigen retrieval in TEG buffer (10 mM Tris pH 9, 0.5 mM EGTA) and blocking of aldehyde groups in 50 mM NH4Cl in PBS for 30 min. The sections were washed in 1% bovine serum albumin (BSA), 0.2% gelatin and 0.05% saponin in PBS and labeled with mouse anti‐E‐cadherin (1:100, sc‐8426, Santa Cruz Biotechnology, Dallas, TX, USA) and rabbit anti‐AQP3 (1:400, AQP‐003, Alomone Labs, Jerusalem, Israel) antibodies diluted in 0.1% BSA and 0.3% Triton X‐100 in PBS in a humidity chamber at 4 °C overnight. The following day, the sections were allowed to adjust to room temperature, washed in 0.1% BSA, 0.2% gelatin and 0.05% saponin in PBS and incubated for 60 min in secondary horseradish peroxidase‐conjugated goat anti‐mouse (1:500, P0447, Agilent Technologies, Santa Clara, CA, USA) or goat anti‐rabbit antibodies (1:500, P0448, Agilent Technologies) and developed with 3,3′‐diaminobenzidine (DAB; K3468, Agilent Technologies). Finally, the sections were counterstained in Mayer's hematoxylin before dehydration and mounting. Staining of serial sections was performed to enable qualitative evaluation of staining patterns. No DAB reactivity was observed on negative control sections without incubation with primary antibodies. For histological evaluation, skin sections were stained with Mayer's hematoxylin and eosin.MicroscopyControl skin sections were imaged on a Leica DMLB bright‐field microscope equipped with a 20×/0.40 air objective and an Invenio 6EIII camera, which was controlled by Deltapix software. Wound edge skin sections were imaged on a Zeiss LSM 710 microscope equipped with a 10×/0.30 air objective and an Axiocam MRc camera, which was controlled by Zen Blue software. Image preparation was performed in ImageJ (25).RESULTS AND DISCUSSIONPatient dataAll samples from chronic wounds were obtained from lower extremity ulcers all located below knee level. Of the six patients included four were male (66.7%) and two were female (33.3%). The mean (SD) age was 75.7 (6.7) years with a range of 68–89 years. Diabetes was present in two (33.3%) of six patients. No patients were active smokers, four were former smokers and two had never smoked. All patients reported alcohol consumption within limits of the national recommendations by the Danish health government (<7 units/week). The mean (SD) wound age was 24.8 (SD 13.8) months. Four wounds were primarily attributed to chronic venous insufficiency (66.7%), one to arterial disease (16.7%), and one wound had a venous and an arterial component (16.7%).Histological evaluation of human chronic woundsSections of skin biopsies from the edge of human chronic wounds (n = 9) were stained with hematoxylin and eosin and histologically evaluated. A clear transition from intact epidermis to the wound edge, defined in this study by loss of epidermal cells, was observed in six out of nine chronic wound samples (Fig. 1A). The remaining three samples showed no loss of epidermis, indicating that the wound edge was not present in these samples, and therefore, they were excluded from the study (data not shown). Furthest from the wound edge, in the surrounding skin, the epidermis was intact and well organized with clear basal cell organization, which was in contrast to the decreased organization and thinner epidermis closer toward the wound edge. At the wound edge, the epidermis was disorganized prior to complete loss in the actual wound (Fig. 1A).1Fig.Histopathological evaluation of epidermis near and at the edge of human chronic wounds. (A) Representative images of a skin section from a human chronic wound stained with hematoxylin and eosin. The epidermis is intact and well‐organized 3 mm from the wound edge (left) and less organized 1 mm from the wound edge (middle). At the wound edge, the epidermis is disorganized and then disrupted (right). The black line marks the outline of the epidermis. (B) Representative images of sections from three chronic human wounds (1–3) stained with hematoxylin and eosin. In the intact epidermis near the chronic wound, different histological changes were observed among the patients, including hyperplastic epidermis (1 + 2), parakeratotic (1) and orthokeratotic (2) hyperkeratosis, hypergranulosis (2), spongiosis (2 + 3), elongated, thickened and irregular rete ridges (3), and dermal inflammation (3). Scale bar: 50 μm.In the intact epidermis near the wound edge, different histopathological characteristics were observed (Fig. 1B). The epidermis near the wound edge was intact and well organized, but showed epidermal hyperplasia (5 of 6) characterized by increased thickness of the epidermis due to an increased number of epidermal cells. In most of the samples, elongated, thickened, and/or irregular rete ridges were present (5 of 6). Hyperkeratosis, characterized by increased thickness of the stratum corneum, was observed in all samples with the presence of both non‐nucleated (orthokeratosis, 2 of 6) and nucleated (parakeratosis, 5 of 6) keratinocytes, indicating incomplete keratinocyte differentiation. Lastly, we observed different levels of epidermal intercellular edema (spongiosis, 5 of 6), characterized by widened intercellular spaces between epidermal cells with elongation of the intercellular junctions, and dermal inflammation (6 of 6; Fig. 1B).Our histopathological observations are consistent with previous studies of chronic wounds, reporting loss of the intact epidermis at the wound edge (26) and hyperplasia, hyperkeratosis and spongiosis in the intact epidermis near the wound edge (26–28).The expression of E‐cadherin and AQP3 is decreased in the epidermis of human chronic wound edgesTo investigate the expression of E‐cadherin and AQP3 in the wound edge of human chronic wounds, serial sections of control skin biopsies and chronic wound edge biopsies were immunohistochemically labeled with antibodies directed against E‐cadherin and AQP3. In control skin, E‐cadherin and AQP3 were localized to the plasma membrane of epidermal cells from stratum basale to stratum granulosum, as previously reported (10–12) (Fig. 2A). Lower expression of E‐cadherin and AQP3 was observed in stratum granulosum, whereas no immunolabeling was detected in stratum corneum and in the dermis (Fig. 2A), similarly to previous reports (10–12).2Fig.In chronic human wounds, the expression of E‐cadherin and AQP3 is downregulated in keratinocytes at the wound edge. (A) Immunohistochemical and hematoxylin and eosin staining of control human skin sections. Immunohistochemical evaluation of E‐cadherin and AQP3 in serial sections of control human skin demonstrates plasma membrane localization of both E‐cadherin and AQP3 in stratum basale (SB) and stratum spinosum (SS) (arrows). Lower expression of E‐cadherin and AQP3 was observed in stratum granulosum (SG) (arrowheads), whereas no immunolabeling was detected in stratum corneum (SC) and in the dermis. (B,C) Immunohistochemical staining of E‐cadherin and AQP3 in serial sections of human chronic wounds. (B) In intact epidermis, E‐cadherin and AQP3 are localized to the plasma membrane in stratum granulosum, stratum spinosum, and stratum basale near the wound edge (arrows), but with low expression in stratum basale in three of six samples. At the wound edge, E‐cadherin and AQP3 expression is markedly decreased (arrowheads). (C) Three different chronic wound edges demonstrating decrease of E‐cadherin and AQP3 expression. Scale bar: 30 μm.In the intact epidermis near the wound edge of all the human chronic wounds, E‐cadherin and AQP3 were observed in the plasma membrane of epidermal cells from stratum basale to stratum granulosum (6 of 6), but in some samples, low expression was observed in stratum basale (3 of 6). Closer to the wound edge, the epidermis was thinner and less organized, but plasma membrane localization of E‐cadherin and AQP3 could still be observed. At the wound edge, the expression of both E‐cadherin and AQP3 was markedly decreased in all samples (6 of 6; Fig. 2B). The wound edges were histologically very different, but common to all of the wounds was the decrease of E‐cadherin and AQP3 expression at the wound edge (Fig. 2C). Interestingly, regulation of E‐cadherin and AQP3 expression may be interdependent in skin since E‐cadherin is decreased in human keratinocytes after siRNA‐mediated knockdown of AQP3 (29).Like adherens junctions, tight junctions are also essential in collective cell migration in skin wound healing (30). Loss of tight junction proteins claudin‐1 and occludin has been observed in wound edges of human chronic wounds, whereas they were present in human acute wounds (31). We speculate if downregulation of tight junction proteins combined with adherens junctions at the wound edge of human chronic wounds might contribute to the pathophysiology of the chronic wounds by impairing skin repair due to decreased migratory capacity of the epidermal cells as well as reduced barrier function. However, E‐cadherin expression has been found to be almost absent in the wound front in an acute wound model using human skin xenograft (21). These observations are made in the wound front with intact epidermis, without any observations from the specific wound edge (transition from intact epidermis to loss of epidermal cells). In this study, we observe a downregulation of E‐cadherin in the wound edge of human chronic wounds. Further studies are needed to confirm if E‐cadherin is also downregulated at the wound edge of acute wounds.Since AQP3‐deficient human keratinocytes show decreased collective cell migration and cell proliferation in vitro and delayed wound healing is observed in AQP3‐null mice, reduced AQP3 expression may decrease migration of cells into the wound thereby contributing to the impaired wound healing in the chronic wounds. Besides defective cell migration, dysregulation of AQP3 expression has been shown to be involved in many different skin conditions. AQP3 expression is increased in the human epidermis of burn wounds and atopic eczema (32, 33) and mislocalized in human epidermis of psoriatic lesions (11).CONCLUSIONIn conclusion, we show a downregulation of E‐cadherin and AQP3 in the wound edge of human chronic wounds. Since there are no reports about AQP3 in the wound edge of human acute wounds, and E‐cadherin is downregulated in the wound front, not wound edge, of human acute wounds, further studies are needed to determine if the downregulation of E‐cadherin and AQP3 in chronic wounds is involved in the wounds failure to heal. If so, it should be determined if E‐cadherin and AQP3 are potential intervention targets for wound healing in chronic wounds and other skin diseases associated with dysregulation of adherens junctions and AQP3. The authors would like to express their gratitude to the nursing and medical staff at the Copenhagen Wound Healing Center, Bispebjerg Hospital and the patients who offered their participation and made it possible to collect samples from chronic wounds. We are also grateful to consultant pathologist, associate clinical professor, Henrik Hager, Department of Pathology, Aarhus University Hospital, for patient skin samples, and to Vibeke Secher Dam for technical assistance.FUNDINGCollection of samples from patients with chronic wounds was performed with financial support from Novo Nordisk Challenge Program (NNF19OC0056411) that also supported MD. A.K.S. Iversen. Novo Nordisk foundation (Tandem Program 2019 #0054390) generously provided financial support for Asst. Prof. L. Bay and Professor T. Bjarnsholt. This project was supported by a grant from the Graduate School of Health (ClinFO), Aarhus University, Denmark to C. Ernstsen.CONFLICT OF INTERESTThe authors declare that they have no conflicts of interest.REFERENCESBaroni A, Buommino E, De Gregorio V, Ruocco E, Ruocco V, Wolf R. Structure and function of the epidermis related to barrier properties. Clin Dermatol. 2012;30:257–62.Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 2009;17:763–71.Sen CK. Human wounds and its burden: an updated compendium of estimates. Adv Wound Care (New Rochelle). 2019;8:39–48.Falanga V, Isseroff RR, Soulika AM, Romanelli M, Margolis D, Kapp S, et al. Chronic wounds. Nat Rev Dis Primers. 2022;8:50.Martin P. Wound healing–aiming for perfect skin regeneration. Science. 1997;276:75–81.Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83:835–70.Friedl P, Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol. 2009;10:445–57.Usui ML, Mansbridge JN, Carter WG, Fujita M, Olerud JE. Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds. J Histochem Cytochem. 2008;56:687–96.Perez‐Moreno M, Jamora C, Fuchs E. Sticky business: orchestrating cellular signals at adherens junctions. Cell. 2003;112:535–48.Ohtani T, Memezawa A, Okuyama R, Sayo T, Sugiyama Y, Inoue S, et al. Increased Hyaluronan production and decreased E‐cadherin expression by cytokine‐stimulated keratinocytes lead to spongiosis formation. J Invest Dermatol. 2009;129:1412–20.Voss KE, Bollag RJ, Fussell N, By C, Sheehan DJ, Bollag WB. Abnormal aquaporin‐3 protein expression in hyperproliferative skin disorders. Arch Dermatol Res. 2011;303:591–600.Sougrat R, Morand M, Gondran C, Barre P, Gobin R, Bonte F, et al. Functional expression of AQP3 in human skin epidermis and reconstructed epidermis. J Invest Dermatol. 2002;118:678–85.Frigeri A, Gropper MA, Umenishi F, Kawashima M, Brown D, Verkman AS. Localization of MIWC and GLIP water channel homologs in neuromuscular, epithelial and glandular tissues. J Cell Sci. 1995;108:2993–3002.Agren J, Zelenin S, Svensson LB, Nejsum LN, Nielsen S, Aperia A, et al. Antenatal corticosteroids and postnatal fluid restriction produce differential effects on AQP3 expression, water handling, and barrier function in perinatal rat epidermis. Dermatol Res Pract. 2010;2010:789729.Agren J, Zelenin S, Hakansson M, Eklof AC, Aperia A, Nejsum LN, et al. Transepidermal water loss in developing rats: role of aquaporins in the immature skin. Pediatr Res. 2003;53:558–65.Hara‐Chikuma M, Verkman AS. Aquaporin‐3 functions as a glycerol transporter in mammalian skin. Biol Cell. 2005;97:479–86.Login FH, Jensen HH, Pedersen GA, Koffman JS, Kwon TH, Parsons M, et al. Aquaporins differentially regulate cell‐cell adhesion in MDCK cells. FASEB J. 2019;33:6980–94.Li L, Hartley R, Reiss B, Sun Y, Pu J, Wu D, et al. E‐cadherin plays an essential role in collective directional migration of large epithelial sheets. Cell Mol Life Sci. 2012;69:2779–89.Hunter MV, Lee DM, Harris TJ, Fernandez‐Gonzalez R. Polarized E‐cadherin endocytosis directs actomyosin remodeling during embryonic wound repair. J Cell Biol. 2015;210:801–16.Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig‐CAMs in cancer. Nat Rev Cancer. 2004;4:118–32.Kashgari G, Venkatesh S, Refuerzo S, Pham B, Bayat A, Klein RH, et al. GRHL3 activates FSCN1 to relax cell‐cell adhesions between migrating keratinocytes during wound reepithelialization. JCI. Insight. 2021;6:e142577.Papadopoulos MC, Saadoun S, Verkman AS. Aquaporins and cell migration. Pflugers Arch. 2008;456:693–700.Hara‐Chikuma M, Verkman AS. Aquaporin‐3 facilitates epidermal cell migration and proliferation during wound healing. J Mol Med (Berl). 2008;86:221–31.Sugimoto T, Huang L, Minematsu T, Yamamoto Y, Asada M, Nakagami G, et al. Impaired aquaporin 3 expression in reepithelialization of cutaneous wound healing in the diabetic rat. Biol Res Nurs. 2013;15:347–55.Schindelin J, Arganda‐Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open‐source platform for biological‐image analysis. Nat Methods. 2012;9:676–82.Misciali C, Dika E, Baraldi C, Fanti PA, Mirelli M, Stella A, et al. Vascular leg ulcers: histopathologic study of 293 patients. Am J Dermatopathol. 2014;36:977–83.Brem H, Stojadinovic O, Diegelmann RF, Entero H, Lee B, Pastar I, et al. Molecular markers in patients with chronic wounds to guide surgical debridement. Mol Med. 2007;13:30–9.Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, Stallcup M, et al. Molecular pathogenesis of chronic wounds: the role of beta‐catenin and c‐myc in the inhibition of epithelialization and wound healing. Am J Pathol. 2005;167:59–69.Kim NH, Lee AY. Reduced aquaporin3 expression and survival of keratinocytes in the depigmented epidermis of vitiligo. J Invest Dermatol. 2010;130:2231–9.Du D, Xu F, Yu L, Zhang C, Lu X, Yuan H, et al. The tight junction protein, occludin, regulates the directional migration of epithelial cells. Dev Cell. 2010;18:52–63.Volksdorf T, Heilmann J, Eming SA, Schawjinski K, Zorn‐Kruppa M, Ueck C, et al. Tight junction proteins Claudin‐1 and Occludin are important for cutaneous wound healing. Am J Pathol. 2017;187:1301–12.Sebastian R, Chau E, Fillmore P, Matthews J, Price LA, Sidhaye V, et al. Epidermal aquaporin‐3 is increased in the cutaneous burn wound. Burns. 2015;41:843–7.Olsson M, Broberg A, Jernae M, Carlsson L, Rudemo M, Suurkula M, et al. Increased expression of aquaporin 3 in atopic eczema. Allergy. 2006;61:1132–7.

Journal

ApmisWiley

Published: Aug 1, 2023

Keywords: Aquaporin‐3; cell migration; chronic wounds; E‐cadherin; skin

There are no references for this article.